Approximately 4% of RA patients treated with or without MTX, TNF inhibitors, and other biologic drugs showed clonal expansions of mainly CD8+ and occasionally CD4+ T-LGL [10]. This evidence concerns the gene CD8A and rheumatoid arthritis.